TradingNote
Gurus

Top Investors

Warren BuffettCathie WoodLi LuRay DalioBill AckmanView all Top Investors
Archive
Industry

AI & Compute

Semiconductors & AcceleratorsCloud & AI PlatformsData Center & NetworkingView all AI & Compute
Research

ALPN

Alpine Immune Sciences, Inc.

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
BlackRockInvestor
$-141.7M
ExitQ2 2024
$142M
--
--
Ken GriffinCitadel Advisors
$-8.5M
ExitQ2 2024
$8.5M
--
--
Steven CohenPoint72
$-4.4M
ExitQ2 2024
$4.4M
--
--
Paul Tudor Jones IITudor Investment
$-2.0M
ExitQ2 2024
$2.0M
--
--
Jefferies GroupInvestor
$-1.4M
ExitQ2 2024
$1.4M
--
--
Jim SimonsRenaissance Technologies
$-9.7K
ExitQ2 2024
$9.7k
--
--
Trade ALPN

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.

CEO
Mitchell H. Gold
IPO Date
Jun 17, 2015

Market Data

OpenThe first traded price for the current trading session.
$64.98
HighThe highest traded price in the current trading session.
$65.00
LowThe lowest traded price in the current trading session.
$64.97
VolumeTotal shares traded during the current trading session.
4.3M
Avg VolumeAverage number of shares traded per session, as reported by FMP.
2.5M
52W HighThe highest traded price over the past 52 weeks.
$65.00
52W LowThe lowest traded price over the past 52 weeks.
$8.33

Valuation

Market CapCompany equity value based on share price multiplied by shares outstanding.
$4.5B
Enterprise ValueMarket cap plus debt and other claims, less cash and equivalents.
$4.4B
Dividend YieldAnnualized dividend yield relative to the current share price.
0.00%

Financials

Free Cash FlowOperating cash flow minus capital expenditures from the latest annual cash flow statement.
$-79M
RevenueTotal sales from the latest annual income statement.
$59M
Net IncomeProfit after expenses and taxes from the latest annual income statement.
$-32M
CashCash and equivalents, or cash plus short-term investments, from the latest balance sheet.
$44M
DebtTotal debt from the latest balance sheet.
$9.9M

Events

EarningsMay 9

EPS est. -0.43 · actual -0.28

Modern Market Industries

AI & Compute

  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking

Software & Digital

  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media

Healthcare

  • GLP-1 & Metabolic Health
  • Biotech & Oncology
  • Medical Devices & Diagnostics
  • Healthcare Services
  • Pharmaceuticals

Finance & Energy

  • Banks & Capital Markets
  • Asset Management & Exchanges
  • Insurance
  • Payments & Fintech
  • Digital Assets
  • Oil, Gas & Fuels

Modern categories

  • AI & Compute Infrastructure
  • Software & Digital Platforms
  • Healthcare Innovation
  • Financial Infrastructure
  • Energy & Grid

Detailed industries

  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking
  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media

Action types

  • Investor actions
  • Insider Trades
  • Congress Trades
  • Stocks

Browse

  • Archive
  • Industries
  • Categories
  • Investors
  • Watchlist
© 2026 TradingNote
ArchiveIndustriesCategoriesInvestorsWatchlist